Comparative Effectiveness, Cost and Outcomes Research Center, University of Washington, Seattle, USA.
BMC Musculoskelet Disord. 2012 Mar 29;13:48. doi: 10.1186/1471-2474-13-48.
BACKGROUND: Lumbar spinal stenosis is one of the most common causes of low back pain among older adults and can cause significant disability. Despite its prevalence, treatment of spinal stenosis symptoms remains controversial. Epidural steroid injections are used with increasing frequency as a less invasive, potentially safer, and more cost-effective treatment than surgery. However, there is a lack of data to judge the effectiveness and safety of epidural steroid injections for spinal stenosis. We describe our prospective, double-blind, randomized controlled trial that tests the hypothesis that epidural injections with steroids plus local anesthetic are more effective than epidural injections of local anesthetic alone in improving pain and function among older adults with lumbar spinal stenosis. METHODS: We will recruit up to 400 patients with lumbar central canal spinal stenosis from at least 9 clinical sites over 2 years. Patients with spinal instability who require surgical fusion, a history of prior lumbar surgery, or prior epidural steroid injection within the past 6 months are excluded. Participants are randomly assigned to receive either ESI with local anesthetic or the control intervention (epidural injections with local anesthetic alone). Subjects receive up to 2 injections prior to the primary endpoint at 6 weeks, at which time they may choose to crossover to the other intervention.Participants complete validated, standardized measures of pain, functional disability, and health-related quality of life at baseline and at 3 weeks, 6 weeks, and 3, 6, and 12 months after randomization. The primary outcomes are Roland-Morris Disability Questionnaire and a numerical rating scale measure of pain intensity at 6 weeks. In order to better understand their safety, we also measure cortisol, HbA1c, fasting blood glucose, weight, and blood pressure at baseline, and at 3 and 6 weeks post-injection. We also obtain data on resource utilization and costs to assess cost-effectiveness of epidural steroid injection. DISCUSSION: This study is the first multi-center, double-blind RCT to evaluate the effectiveness of epidural steroid injections in improving pain and function among older adults with lumbar spinal stenosis. The study will also yield data on the safety and cost-effectiveness of this procedure for older adults. TRIAL REGISTRATION: Clinicaltrials.gov NCT01238536.
背景:腰椎管狭窄症是老年人腰痛的最常见原因之一,可导致严重残疾。尽管其发病率很高,但对脊柱狭窄症症状的治疗仍存在争议。硬膜外类固醇注射越来越多地被用作一种比手术更具侵入性、潜在更安全、更具成本效益的治疗方法。然而,缺乏数据来判断硬膜外类固醇注射治疗脊柱狭窄症的有效性和安全性。我们描述了一项前瞻性、双盲、随机对照试验,该试验检验了这样一个假设,即在改善患有腰椎管狭窄症的老年人的疼痛和功能方面,硬膜外类固醇注射加局部麻醉比单独使用硬膜外局部麻醉注射更有效。
方法:我们将在 2 年内从至少 9 个临床地点招募多达 400 名患有腰椎中央管狭窄症的患者。排除有脊柱不稳定需要手术融合、有腰椎手术史或在过去 6 个月内接受过硬膜外类固醇注射的患者。参与者被随机分配接受 ESI 加局部麻醉或对照干预(单独硬膜外注射局部麻醉)。在 6 周的主要终点之前,受试者最多接受 2 次注射,此时他们可以选择交叉到另一种干预措施。参与者在基线和 3 周、6 周以及随机分组后 3、6 和 12 个月时完成经过验证的标准化疼痛、功能障碍和健康相关生活质量测量。主要结局是 Roland-Morris 残疾问卷和 6 周时疼痛强度的数字评分量表测量。为了更好地了解其安全性,我们还在基线时以及注射后 3 和 6 周测量皮质醇、HbA1c、空腹血糖、体重和血压。我们还获得了资源利用和成本数据,以评估硬膜外类固醇注射的成本效益。
讨论:这项研究是第一项评估硬膜外类固醇注射对改善老年腰椎管狭窄症患者疼痛和功能的多中心、双盲 RCT。该研究还将提供有关该程序对老年人安全性和成本效益的数据。
试验注册:Clinicaltrials.gov NCT01238536。
Drug Des Devel Ther. 2015-1-30
N Engl J Med. 2014-7-3
BMC Musculoskelet Disord. 2022-7-21
BMC Med Inform Decis Mak. 2015-5-28
Spine (Phila Pa 1976). 2010-11-1
N Engl J Med. 2009-8-6
N Engl J Med. 2009-8-6
Curr Rev Musculoskelet Med. 2008-3
J Affect Disord. 2009-4